Chewy (NYSE:CHWY) Given “Neutral” Rating at JPMorgan Chase & Co.

Chewy (NYSE:CHWY)‘s stock had its “neutral” rating reiterated by research analysts at JPMorgan Chase & Co. in a research report issued on Friday, Benzinga reports. They currently have a $24.00 price objective on the stock, down from their prior price objective of $29.00. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 13.66% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. Raymond James Financial boosted their target price on shares of Chewy from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Friday, September 4th. Rosenblatt Securities cut their target price on Chewy from $25.00 to $24.00 and set a “neutral” rating on the stock in a research report on Thursday. UBS Group restated a “neutral” rating on shares of Chewy in a research note on Thursday. Morgan Stanley lowered their price target on Chewy from $37.00 to $36.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, Citigroup reissued a “market outperform” rating on shares of Chewy in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, Chewy currently has an average rating of “Moderate Buy” and an average price target of $30.82.

Chewy Stock Performance

Shares of CHWY stock opened at $21.11 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.35 and a debt-to-equity ratio of 1.59. Chewy has a 12-month low of $17.40 and a 12-month high of $40.55. The business’s 50 day moving average is $22.44 and its two-hundred day moving average is $23.09. The company has a market capitalization of $8.64 billion, a P/E ratio of 31.99, a P/E/G ratio of 0.83 and a beta of 1.42.

Chewy (NYSE:CHWY) last issued its quarterly earnings results on Wednesday, September 9th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.18 by $0.18. Chewy had a net margin of 2.09% and a return on equity of 60.88%. The company had revenue of $3.33 billion during the quarter, compared to analyst estimates of $3.32 billion. During the same quarter in the previous year, the firm earned $0.33 EPS. The firm’s revenue was up 7.3% compared to the same quarter last year. Analysts expect that Chewy will post 0.8 EPS for the current fiscal year.

Insider Activity

In other news, General Counsel Da-Wai Hu sold 4,203 shares of the business’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $19.49, for a total value of $81,916.47. Following the transaction, the general counsel owned 4,103 shares of the company’s stock, valued at approximately $79,967.47. The trade was a 50.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.34% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Chewy

A number of institutional investors and hedge funds have recently modified their holdings of CHWY. Royal Bank of Canada raised its position in shares of Chewy by 2.5% during the 1st quarter. Royal Bank of Canada now owns 220,509 shares of the company’s stock worth $7,168,000 after purchasing an additional 5,466 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Chewy in the first quarter valued at $510,000. NewEdge Advisors LLC lifted its stake in shares of Chewy by 5,238.3% in the 1st quarter. NewEdge Advisors LLC now owns 32,510 shares of the company’s stock valued at $1,057,000 after purchasing an additional 31,901 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Chewy by 1.5% during the first quarter. Goldman Sachs Group Inc. now owns 1,176,138 shares of the company’s stock worth $38,236,000 after buying an additional 17,788 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Chewy by 31.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 383,966 shares of the company’s stock worth $12,483,000 after purchasing an additional 92,129 shares during the period. Institutional investors and hedge funds own 93.09% of the company’s stock.

More Chewy News

Here are the key news stories impacting Chewy this week:

• Positive Sentiment: Chewy reported revenue of $3.33 billion, up 7.3% year over year and slightly above estimates, while adjusted EPS of $0.36 was in line with or above consensus depending on the measure used. Active customers increased 3.8% to 21.7 million, and Autoship sales reached $2.82 billion, or 84.6% of revenue. Chewy Q2 Revenue Rises 7.3% to $3.33 Billion
• Positive Sentiment: Management raised its fiscal 2026 revenue outlook to $13.5 billion-$13.6 billion and increased its profitability outlook. Stable demand for essential pet products, market-share gains, Autoship growth and AI-related cost savings support the improved forecast. Chewy Q2 Earnings Call Highlights Stable Demand and Higher Outlook
• Positive Sentiment: Some analysts remain constructive: Citizens JMP reaffirmed an outperform rating with a $28 target, while TD Cowen and Bank of America maintained Buy ratings despite trimming their targets. Analysts also cited Chewy’s potential expansion into higher-margin services, including veterinary care. Chewy Buy Rating Reaffirmed
• Neutral Sentiment: The quarter was broadly solid but not a major upside surprise: gross margin was flat at 30.4%, and analysts described the near-term catalyst path as limited because pet-category growth remains modest.
• Negative Sentiment: Free cash flow missed expectations, while acquisition-related spending and lower liquidity raised balance-sheet concerns. Investors also questioned whether reported profit benefited from temporary factors rather than durable operating improvement. Chewy Free Cash Flow Miss Overshadows Raised Outlook
• Negative Sentiment: Consumers are reducing discretionary purchases such as pet treats, and Evercore ISI downgraded the stock, citing slowing organic growth and few catalysts. Rosenblatt also cut its target to $24 and adopted a Neutral rating. Analyst Downgrade on Limited Catalysts

About Chewy

Chewy, Inc is an e-commerce company focused on pet products and services. Through its website and mobile applications, the company sells pet food, treats, supplies, toys, bedding, medications, and other products for dogs, cats, fish, birds, reptiles, and small pets.

Chewy supports recurring purchases through its Autoship program and provides access to prescription and over-the-counter pet medications through Chewy Pharmacy. The company also offers pet health-related services, including veterinary consultations in certain markets, and sells products under a range of national and private-label brands.